References
- Eiland E, Nzerue C, Faulkner M. Preeclampsia 2012. J Pregnancy. 2012;2012:586578.
- Winn VD, Gormley M, Paquet AC, et al. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology. 2009;150:452–462.
- Savvatis K, Westermann D, Schultheiss HP, et al. Kinins in cardiac inflammation and regeneration: insights from ischemic and diabetic cardiomyopathy. Neuropeptides. 2010;44:119–125.
- Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev. 1992;44:1–80.
- Sharma JN. Interrelationship between the kallikrein-kinin system and hypertension: a review. Gen Pharmacol. 1988;19:177–187.
- Wang J, Xiong W, Yang Z, et al. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension. 1994;23:236–243.
- Uchiyama M, Otsuka T, Sakai K. Urinary kallikrein excretion in children of parents with essential hypertension. Arch Dis Child. 1985;60:974–975.
- Overlack A, Stumpe KO, Kolloch R, et al. Antihypertensive effect of orally administered glandular kallikrein in essential hypertension: results of double blind study. Hypertension. 1981;3:I18–21.
- Mohamed M, Larmie ET, Singh HJ, et al. Tissue kallikrein and kininogen levels in fetoplacental tissues from normotensive pregnant women and women with pregnancy-induced hypertension. Eur J Obstet Gynecol Reprod Biol. 2007;134:15–19.
- National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy, Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22.
- American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstetrics Gynecol. 2013;122:1122–1131.
- Snydal S. Major changes in diagnosis and management of preeclampsia. J Midwifery Womens Health. 2014;59:596–605.
- Waeckel L, Potier L, Richer C, et al. Pathophysiology of genetic deficiency in tissue kallikrein activity in mouse and man. Thromb Haemost. 2013;110:476–483.
- Alhenc-Gelas F, Girolami J. Molecular and genetic aspects of the kallikrein kinin sytem. In: Kinins. Berlin: De Gruyter Gmbh; 2011. p. 7–32.
- Marceau F, Regoli D. Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov. 2004;3:845–852.
- Waeckel L, Potier L, Chollet C, et al. Antihypertensive role of tissue kallikrein in hyperaldosteronism in the mouse. Endocrinology. 2012;153:3886–3896.
- Madeddu P, Emanueli C, El-Dahr S. Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling. Nat Clin Pract Nephrol. 2007;3:208–221.
- Hecquet C, Tan F, Marcic BM, et al. Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases. Mol Pharmacol. 2000;58:828–836.
- Mombouli JV. ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide. Drugs. 1997;54(Suppl 5):12–22.
- Bergaya S, Meneton P, Bloch-Faure M, et al. Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice. Circ Res. 2001;88:593–599.
- Azizi M, Boutouyrie P, Bissery A, et al. Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans. J Clin Invest. 2005;115:780–787.
- Millar JG, Campbell SK, Albano JD, et al. Early prediction of pre-eclampsia by measurement of kallikrein and creatinine on a random urine sample. Br J Obstet Gynaecol. 1996;103:421–426.
- Khedun SM, Naicker T, Moodley J. Tissue kallikrein activity in pregnancy. Aust N Z J Obstet Gynaecol. 2000;40:451–454.
- Valdés G, Acuña S, Munizaga A, et al. Utero-placental cellular and nuclear expression of bradykinin B2 receptors in normal and preeclamptic pregnancies. Pregnancy Hypertens. 2016;6:30–37.
- Murphy SR, LaMarca B, Cockrell K, et al. L-Arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats. Am J Physiol Regul Integr Comp Physiol. 2012;302:R259–263.
- Gryglewski RJ, Uracz W, Chłopicki S, et al. Bradykinin as a major endogenous regulator of endothelial function. Pediatr Pathol Mol Med. 2002;21:279–290.